Skip to content
My WebMD Sign In, Sign Up

Skin Problems & Treatments Health Center

Font Size

Orbactiv Approved for Drug-Resistant Skin Infections

Third such antibiotic sanctioned this year

WebMD News from HealthDay

By Scott Roberts

HealthDay Reporter

THURSDAY, Aug. 7, 2014 (HealthDay News) -- The antibacterial drug Orbactiv (oritavancin) has been approved by the U.S. Food and Drug Administration to treat drug-resistant skin infections in adults, the agency said in a news release.

The drug is sanctioned to treat methicillin-resistant Staphylococcus aureus (MRSA) and other acute bacterial skin infections. It's the third such drug approved in 2014, following May approval of Dalvance (dalbavancin) and June approval of Sivextro (tedizolid), the FDA said.

Orbactiv's safety and effectiveness were evaluated in two clinical studies involving almost 2,000 adults. The most common side effects included headache, nausea, vomiting, skin abscesses on the arms and legs, and diarrhea.

The drug's label will include a boxed warning that it could interact with the blood-thinning medication warfarin, the agency said.

Orbactiv is marketed by The Medicines Company, based in Parsippany, N.J.

Today on WebMD

chafing
Pictures and symptoms of the red, scaly rash.
woman with dyed dark hair
What it says about your health.
 
woman with cleaning products
Top causes of the itch that rashes.
atopic dermatitus
Identify and treat common skin problems.
 
itchy skin
Article
shingles rash on skin
Article
 
woman with skin tag
Quiz
Woman washing face
Video
 

Itching for Relief?

Get Help With the

Loading ...

Sending your email...

This feature is temporarily unavailable. Please try again later.

Thanks!

Now check your email account on your mobile phone to download your new app.

woman washing her hair in sink
Video
close up of womans bare neck
Tools
 
Feet
Slideshow
woman with face cream
Quiz